Navigation Links
Global study shows all tobacco bad for the heart

A major Canadian-led global study has found all forms of tobacco exposure, whether that be smoking, chewing or inhaling second hand smoke, increase the risk of heart attack.

The study by professors Salim Yusuf and Koon Teo of the Michael G. DeGroote School of Medicine at McMaster University and Hamilton Health Sciences in Hamilton, is published in this week's issue of The Lancet.

In collaboration with colleagues from 52 countries, they calculated the risk of heart attack for various forms of active tobacco use (both smoking and non-smoking) and second hand smoking in all areas of the world. The INTERHEART study included data from more than 27,000 people in 52 countries. In their calculations, the investigators accounted for other lifestyle factors that could affect the heart attack risk, such as diet and age.

They found that tobacco use in any form, including sheesha smoking popular in the Middle East and beedie smoking common in South Asia, was harmful. Compared to people who had never smoked, smokers had a three-fold increased risk of a heart attack. Even those with relatively low levels of exposure of eight to 10 cigarettes a day doubled their risk of heart attack. Each cigarette smoked per day, increased the risk by 5.6 per cent.

However, the researchers did find that the risk of heart attack decreased with time after stopping smoking. Light smokers, those who consume fewer than 10 cigarettes a day, benefit the most. They have no excess risk three to five years after quitting. By contrast, moderate and heavy smokers of 20 or more cigarettes a day still had an excess risk of around 22 per cent, 20 years after quitting.

The team also found that exposure to second hand smoke increased the risk of heart attack in both former and non-smokers. The findings suggest that individuals with the highest levels of exposure to second hand smoke of 22 hours or more per week may increase their risk of heart attack by around 45%. '"/>

Source:McMaster University


Page: 1 2 3

Related biology news :

1. Global analysis of membrane proteins
2. Global warming increases oyster sensitivity to pollution
3. Grand Challenges in Global Health initiative funds Yale project
4. Global warming may warrant new approaches to ecosystem restoration
5. Global warming may have damaged coral reefs forever
6. Global malaria map key weapon in fight against malaria, scientists say
7. Global changes alter the timing of plant growth, scientists say
8. Global map shows new patterns of extinction risk
9. Global sunscreen has likely thinned, report NASA scientists
10. Global survey of lizards reveals greater abundance of animals on islands than on mainland ecosystems
11. Bioartificial kidney under study at MCG

Post Your Comments:
(Date:11/8/2009)..., WEST LAFAYETTE, Ind. - Researchers at Purdue Un...ing damaged nerve fibers in spinal cord injuries u...blood shortly after an accident. , The synthetic...out 60 nanometers in diameter, or roughly 100 time..., Researchers have been studying how to deliver d...
(Date:11/6/2009)...To celebrate the 150th anniversary this month of t...erican Institute of Biological Sciences (AIBS) is ...about Charles Darwin and his historic insights int...an of the University of California, Berkeley, and ...ian,s article, "Ten Myths About Charles Darwin," a...
(Date:11/5/2009)...The National Association of Biology Teachers (NABT...f biological sciences at Naugatuck Valley Communit...he 2009 Evolution Education Award during the NABT ...eld 11-14 November 2009 in Denver, Colorado. , T... American Institute of Biological Sciences,(AIBS)...
Breaking Biology News(10 mins):Findings show nanomedicine promising for treating spinal cord injuries 2Findings show nanomedicine promising for treating spinal cord injuries 3Biologists, educators recognize excellence in evolution education 2Dietary supplements manufacturers gain new tool to help ensure quality products 9150 1Dietary supplements manufacturers gain new tool to help ensure quality products 9150 2Providence Service Corporation Does Not Expect California Budget Issues to Materially Impact Its Business in the State 50992 1Providence Service Corporation Does Not Expect California Budget Issues to Materially Impact Its Business in the State 50992 2June 2009 Mayo Clinic Womens HealthSource Highlights Summer Skin Problems Low Vision and Pilates 4696 1June 2009 Mayo Clinic Womens HealthSource Highlights Summer Skin Problems Low Vision and Pilates 4696 2June 2009 Mayo Clinic Womens HealthSource Highlights Summer Skin Problems Low Vision and Pilates 4696 3June 2009 Mayo Clinic Womens HealthSource Highlights Summer Skin Problems Low Vision and Pilates 4696 4June 2009 Mayo Clinic Womens HealthSource Highlights Summer Skin Problems Low Vision and Pilates 4696 5
... the number of living species on earth range from ...n species have been classified and described. Esti...ord is an even more daunting task. , One tool ecol...lly relied on to identify patterns of existing bio...umb called the species-area effect: the tendency f...
...ering crowd of various species of bacteria is esse...ts of their chemical conversation are almost unive...t bacteria of different species can talk to each o...pecies can manipulate the conversation to confuse ...misdirection could have important consequences for...
...suggests that medications commonly referred to as ...ack a gene called the estrogen receptor beta. The ...ovulation rates in mice that were genetically engi...n receptor beta is one of two estrogen receptor pr...nes and are present throughout the female reproduc...
Other Biology News:Space matters: Estimating species diversity in the fossil record 2Say what? Bacterial conversation stoppers 2Say what? Bacterial conversation stoppers 3New Discovery May Help Doctors Treat Infertility 2New Discovery May Help Doctors Treat Infertility 3
(Date:11/5/2009)... Call on Thursday, November 5, 2009 at 4:30 p.m. E...5 /PRNewswire-FirstCall/ - OncoGenex Pharmaceutica...OGXI ) today reported unaudited financial results ...ber 30, 2009 and reviewed the Company,s highlights...g consolidated results reflect the operations of O...
(Date:11/5/2009)...N.Y., Nov. 5 BioSpecific...ceutical company developing first-in-class collage... results for the third quarter ended September 30,...ptember of this year, the FDA,s Arthritis Advisory...2-0, the approval of XIAFLEX(TM) for the treatment...
(Date:11/5/2009)..., Texas, Nov. 5 Wound Ma...ay that it has entered into a Letter of Intent to ...Health Technologies, Inc. (OTC Bulletin Board: VHG...00 in cash and debt, 4,000,000 shares of WNDM and ... on the Veriscrip technology being acquired from V...
(Date:11/5/2009)...alif., Nov. 5 WaferGen B...ing developer of state-of-the-art genetic analysis...Ph.D. has joined the company,s Scientific Advisory...and commercializing novel molecular diagnostics fo...the development of computational biology systems f...
Breaking Biology Technology:OncoGenex Reports Third Quarter 2009 Financial Results 2OncoGenex Reports Third Quarter 2009 Financial Results 3OncoGenex Reports Third Quarter 2009 Financial Results 4OncoGenex Reports Third Quarter 2009 Financial Results 5OncoGenex Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 7OncoGenex Reports Third Quarter 2009 Financial Results 8BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 2OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 3WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 2WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 3WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 4
... Diagnostics, a,genomics-based diagnostics company...a Commonwealth University School of Medicine has i...TM) Tissue of Origin Test. The new,genomics-based ...n so that,tissue-specific management can begin. VC...n the country to evaluate this leading technology ...
...Nov. 6 Centocor,Inc., Schering-Plough Corporation...ed today that an estimated one million patients ha... the leading anti-tumor necrosis,factor (TNF)-alph...ed to,treat more patients worldwide than all other...first anti-TNF-alpha treatment approved by the,U.S...
...logical Threats Receives Government ... ICx Technologies, a developer of,advanced techno... announced,today a contract award to procure its A...n of airborne biological threats. The AirSentinel,...dvanced Research Projects,Agency (DARPA) and the D...
Other Biology Technology:Virginia Commonwealth University to Study Genomics-Based Diagnostic Test: Pathwork Diagnostics' Tissue of Origin Test Designed to Aid in Determination of a Tumor's Origin 2Virginia Commonwealth University to Study Genomics-Based Diagnostic Test: Pathwork Diagnostics' Tissue of Origin Test Designed to Aid in Determination of a Tumor's Origin 3Virginia Commonwealth University to Study Genomics-Based Diagnostic Test: Pathwork Diagnostics' Tissue of Origin Test Designed to Aid in Determination of a Tumor's Origin 4REMICADE(R) Becomes First Anti-TNF Biologic Therapy to Treat One Million Patients Worldwide 2REMICADE(R) Becomes First Anti-TNF Biologic Therapy to Treat One Million Patients Worldwide 3REMICADE(R) Becomes First Anti-TNF Biologic Therapy to Treat One Million Patients Worldwide 4REMICADE(R) Becomes First Anti-TNF Biologic Therapy to Treat One Million Patients Worldwide 5REMICADE(R) Becomes First Anti-TNF Biologic Therapy to Treat One Million Patients Worldwide 6REMICADE(R) Becomes First Anti-TNF Biologic Therapy to Treat One Million Patients Worldwide 7REMICADE(R) Becomes First Anti-TNF Biologic Therapy to Treat One Million Patients Worldwide 8REMICADE(R) Becomes First Anti-TNF Biologic Therapy to Treat One Million Patients Worldwide 9REMICADE(R) Becomes First Anti-TNF Biologic Therapy to Treat One Million Patients Worldwide 10REMICADE(R) Becomes First Anti-TNF Biologic Therapy to Treat One Million Patients Worldwide 11REMICADE(R) Becomes First Anti-TNF Biologic Therapy to Treat One Million Patients Worldwide 12ICx Awarded Department of Defense Contract for AirSentinel Monitors 2
...emium quality siRNAs you need for your gene silenc... online by providing either the 19-21 base target ...siRNA sequences. (Also check out Ambion's Silencer... are already designed for you.) For your convenien...
Custom siRNA, standard purity from Ambion
...e premium quality siRNAs you need for your gene si...ered online by providing either the 19-21 base tar...nse siRNA sequences. (Also check out Ambion's ...iRNAs, which are already designed for you.) For yo...
...emium quality siRNAs you need for your gene silenc... online by providing either the 19-21 base target ...siRNA sequences. (Also check out Ambion's Silencer... are already designed for you.) For your convenien...
Biology Products: